Daily Intelligence Brief
Daily Docket: Anderson Kill Names 175 September 11 Plaintiffs
We tracked 253 new filings. Terrorist Attacks on September 11, 2001 Litigation (1570) led with 175 filings, with Anderson Kill PC (175). Suboxone Film Litigation (3092) added 18 filings, led by Ketterer Browne & Davani LLC (18). Social Media Adolescent Addiction Litigation (3047) drew 12 filings, led by Bernstein Liebhard LLP (2) and Brockstedt Mandalas Federico LLC (2). See the full filing feed and firm-level breakdowns here.
Missouri Talc Cases Seek Pause as Proposed Resolution Takes Shape
Missouri ovarian-cancer talc plaintiffs and defendants asked a state judge on Sept. 22 for a stay tied to Johnson & Johnson’s proposed $5.5 billion resolution, putting active trial-court litigation on hold while the parties assess participation. The request does not approve the proposed resolution or establish any claimant’s recovery. But a stay would suspend immediate litigation pressure in cases positioned for the deal and shift leverage toward the participation process. For Talcum Powder Products Liability (2738), the motion marks a current procedural test of whether the proposed resolution can convert settlement negotiations into a broader litigation pause.
Birmingham Targets Firefighter Gear Makers Over PFAS Exposure Costs
Birmingham filed suit on Sept. 22 against 3M, DuPont-related entities and other turnout-gear manufacturers, alleging PFAS in firefighters’ protective equipment contaminated city facilities and equipment. The city seeks testing, decontamination and replacement costs, along with compensatory and punitive damages. The action targets alleged property and financial losses rather than individual firefighter-injury claims, but it expands the PFAS exposure record beyond firefighting foam. For Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873), the complaint adds a fresh municipal theory focused on how PFAS-containing products allegedly migrate through fire-service operations and create remediation obligations.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
